SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 244 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,613,738 | +0.9% | 1,654,470 | +10.0% | 0.34% | +48.2% |
| Q2 2023 | $45,224,368 | -10.0% | 1,504,470 | +8.4% | 0.23% | -30.1% |
| Q1 2023 | $50,266,045 | +38.3% | 1,387,415 | +36.1% | 0.33% | +12.4% |
| Q4 2022 | $36,352,010 | +35.2% | 1,019,120 | +28.3% | 0.29% | +69.6% |
| Q3 2022 | $26,881,000 | +17.0% | 794,120 | 0.0% | 0.17% | +26.7% |
| Q2 2022 | $22,966,000 | -19.1% | 794,120 | -9.5% | 0.14% | +5.5% |
| Q1 2022 | $28,375,000 | +55.0% | 877,945 | +39.8% | 0.13% | +85.5% |
| Q4 2021 | $18,311,000 | – | 627,945 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |